GlassScriptPhysician profile
James T Song
NPI 1316918626
$10,640.37
in general payments reported to CMS, 2019-2025
50 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,192 · 2020: $805 · 2021: $1,513 · 2022: $1,318 · 2023: $1,374 · 2024: $1,376 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,811.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,073.08 | 2019-2020 | |
| Teleflex LLC | $1,511.29 | 2021-2024 | Urolift |
| Medtronic, INC. | $1,058.58 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $598.26 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $558.81 | 2019-2025 | Myrbetriq, Xtandi |
| Medtronic USA, INC. | $514.91 | 2019-2020 | |
| Abbvie INC. | $400.75 | 2019-2025 | Lupron Depot |
| Janssen Biotech, INC. | $340.61 | 2019-2022 | |
| Olympus America INC. | $237.01 | 2019-2025 | Itind System |
| Urovant Sciences INC | $203.79 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $201.30 | 2019-2022 | |
| Allergan, INC. | $190.39 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $187.18 | 2019-2023 | Provenge |
| Merck Sharp & Dohme LLC | $182.83 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Ferring Pharmaceuticals INC. | $174.98 | 2024-2025 | Adstiladrin |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $173.65 | 2020-2025 | Speedicath |
| Antares Pharma, INC. | $169.89 | 2019-2025 | Xyosted, Tlando |
| Pfizer INC. | $138.10 | 2019-2025 | |
| Boston Scientific Corporation | $131.56 | 2019-2024 | Spaceoar System |
| Myriad Genetic Laboratories, INC. | $119.14 | 2020-2024 | Prolaris |
| Calyxo, INC. | $110.11 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $101.23 | 2019-2023 | Gentlecath |
| Acerus Pharmaceuticals Corporation | $101.09 | 2020-2022 | |
| Koelis INC. | $100.00 | 2024 | |
| Tolmar, INC. | $94.77 | 2023-2025 | Jatenzo, Eligard |
| Renovia INC | $86.67 | 2019 | |
| Progenics Pharmaceuticals, INC. | $84.55 | 2023-2025 | Pylarify |
| Clarus Therapeutics INC. | $83.32 | 2021 | |
| Urogen Pharma, INC. | $81.89 | 2023-2025 | Jelmyto |
| Srs Medical Systems, INC. | $70.14 | 2019 | |
| Bioprotect Medical, INC. | $68.95 | 2024-2025 | Bioprotect Balloon Implant System |
| Photocure INC | $50.00 | 2021-2023 | Cysview |
| Novartis Pharmaceuticals Corporation | $46.01 | 2019-2025 | |
| Axonics, INC. | $41.24 | 2022-2024 | Axonics |
| Immunitybio, INC. | $37.93 | 2024 | |
| Myovant Sciences INC. | $35.39 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $33.84 | 2019-2024 | Xiaflex |
| Civco Medical Instruments | $30.70 | 2025 | |
| Blue Earth Diagnostics | $27.79 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $21.11 | 2023 | Bard Urinary Drainage Bag |
| Halozyme INC | $21.05 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.67 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $19.58 | 2019 | |
| Dentsply Ih INC. | $17.87 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.74 | 2022 | |
| Laborie Medical Technologies Corp. | $16.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abbott Laboratories | $15.86 | 2021 | |
| Accord Healthcare, INC. | $15.69 | 2022 | |
| Mission Pharmacal Company | $13.55 | 2022 | |
| Aytu Biopharma, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.